Skip to content

Clinical trials

Completed Immunoglobulin Light-chain Amyloidosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Status: Completed Clear all

121 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
20012
20023
20032
20042
20057
20063
20078
200810
20096
20104
20114
20124
20134
20142
20152
20163
20173
20185
20193
20204
20215
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed121

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Medical Center7
Mayo Clinic6
Memorial Sloan Kettering Cancer Center6
Fred Hutchinson Cancer Center5
National Cancer Institute (NCI)5
SWOG Cancer Research Network5
Northwestern University4
The Cleveland Clinic4
University of Tennessee4
European Organisation for Research and Treatment of Cancer - EORTC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis121
Multiple Myeloma67
Leukemia, Lymphocytic, Chronic, B-Cell46
Neoplasms, Plasma Cell46
Lymphoma, Large B-Cell, Diffuse44
Burkitt Lymphoma43
Lymphoma, Follicular43
Lymphoma, Mantle-Cell43
Lymphoma, Non-Hodgkin43
Precursor Cell Lymphoblastic Leukemia-Lymphoma43

Trials

Showing 1 to 25 of 121. Each trial links to its page on Pharma Observatory.

21 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.